Improving return-to-work after childbirth: design of the Mom@Work study, a randomised controlled trial and cohort study

Suzanne G M Stomp-van den Berg, Mireille N M van Poppel, Ingrid J M Hendriksen, David J Bruinvels, Kimi Uegaki, Martine C de Bruijne, Willem van Mechelen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: Many women suffer from health problems after giving birth, which can lead to sick leave. About 30% of Dutch workers are on sick leave after maternity leave. Structural contact of supervisors with employees on maternity leave, supported by early medical advice of occupational physicians, may increase the chances of return-to-work after maternity leave. In addition, to understand the process of sick leave and return-to-work after childbirth it is important to gain insight into which factors hinder return-to-work after childbirth, as well, as which prognostic factors lead to the development of postpartum health complaints. In this paper, the design of the Mom@Work study is described.

METHODS: The Mom@Work study is simultaneously a randomised controlled trial and a cohort study. Pregnant women working for at least 12 hours a week at one of the 15 participating companies are eligible to participate. The supervisors of these pregnant employees are randomised at 35 weeks pregnancy into the intervention group or control group. During maternity leave, supervisors in the intervention group contact their employee six weeks after delivery using a structured interview. When employees do not expect to return to their jobs at the end of their scheduled maternity leave due to health problems, the supervisor offers early support of the occupational physician. Supervisors in the control group have no structural contact with their employees during maternity leave. Measurements take place at 30 weeks pregnancy and at 6, 12, 24 and 52 weeks postpartum. In addition, cost data are collected. For the RCT, primary outcome measures are sick leave and return-to-work, and secondary outcome measures are costs, health, satisfaction with intervention and global feelings of recovery. Outcome measures for the cohort are pregnancy-related pelvic girdle pain, fatigue and depression. Finally, a number of prognostic factors for return-to-work and for the development of complaints will be measured.

DISCUSSION: The Mom@Work study will provide important information about return-to-work of employees after giving birth. Results will give insight in prognosis of postpartum sick leave and complaints. Also, the role of supervisors and occupational physicians in successful return-to-work after childbirth will be clarified.

Original languageEnglish
Pages (from-to)43
JournalBMC Public Health
Volume7
DOIs
Publication statusPublished - 29 Mar 2007

Cite this

@article{686b105794f84c42a5e1a3f76e69df02,
title = "Improving return-to-work after childbirth: design of the Mom@Work study, a randomised controlled trial and cohort study",
abstract = "BACKGROUND: Many women suffer from health problems after giving birth, which can lead to sick leave. About 30{\%} of Dutch workers are on sick leave after maternity leave. Structural contact of supervisors with employees on maternity leave, supported by early medical advice of occupational physicians, may increase the chances of return-to-work after maternity leave. In addition, to understand the process of sick leave and return-to-work after childbirth it is important to gain insight into which factors hinder return-to-work after childbirth, as well, as which prognostic factors lead to the development of postpartum health complaints. In this paper, the design of the Mom@Work study is described.METHODS: The Mom@Work study is simultaneously a randomised controlled trial and a cohort study. Pregnant women working for at least 12 hours a week at one of the 15 participating companies are eligible to participate. The supervisors of these pregnant employees are randomised at 35 weeks pregnancy into the intervention group or control group. During maternity leave, supervisors in the intervention group contact their employee six weeks after delivery using a structured interview. When employees do not expect to return to their jobs at the end of their scheduled maternity leave due to health problems, the supervisor offers early support of the occupational physician. Supervisors in the control group have no structural contact with their employees during maternity leave. Measurements take place at 30 weeks pregnancy and at 6, 12, 24 and 52 weeks postpartum. In addition, cost data are collected. For the RCT, primary outcome measures are sick leave and return-to-work, and secondary outcome measures are costs, health, satisfaction with intervention and global feelings of recovery. Outcome measures for the cohort are pregnancy-related pelvic girdle pain, fatigue and depression. Finally, a number of prognostic factors for return-to-work and for the development of complaints will be measured.DISCUSSION: The Mom@Work study will provide important information about return-to-work of employees after giving birth. Results will give insight in prognosis of postpartum sick leave and complaints. Also, the role of supervisors and occupational physicians in successful return-to-work after childbirth will be clarified.",
keywords = "Adult, Cohort Studies, Confidence Intervals, Employment/statistics & numerical data, Female, Follow-Up Studies, Health Education/methods, Humans, Multivariate Analysis, Netherlands, Parental Leave/standards, Personnel Management/methods, Postpartum Period, Pregnancy, Probability, Research Design, Risk Assessment, Sick Leave/statistics & numerical data, Time Factors, Women, Working/psychology",
author = "{Stomp-van den Berg}, {Suzanne G M} and {van Poppel}, {Mireille N M} and Hendriksen, {Ingrid J M} and Bruinvels, {David J} and Kimi Uegaki and {de Bruijne}, {Martine C} and {van Mechelen}, Willem",
year = "2007",
month = "3",
day = "29",
doi = "10.1186/1471-2458-7-43",
language = "English",
volume = "7",
pages = "43",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",

}

Improving return-to-work after childbirth : design of the Mom@Work study, a randomised controlled trial and cohort study. / Stomp-van den Berg, Suzanne G M; van Poppel, Mireille N M; Hendriksen, Ingrid J M; Bruinvels, David J; Uegaki, Kimi; de Bruijne, Martine C; van Mechelen, Willem.

In: BMC Public Health, Vol. 7, 29.03.2007, p. 43.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Improving return-to-work after childbirth

T2 - design of the Mom@Work study, a randomised controlled trial and cohort study

AU - Stomp-van den Berg, Suzanne G M

AU - van Poppel, Mireille N M

AU - Hendriksen, Ingrid J M

AU - Bruinvels, David J

AU - Uegaki, Kimi

AU - de Bruijne, Martine C

AU - van Mechelen, Willem

PY - 2007/3/29

Y1 - 2007/3/29

N2 - BACKGROUND: Many women suffer from health problems after giving birth, which can lead to sick leave. About 30% of Dutch workers are on sick leave after maternity leave. Structural contact of supervisors with employees on maternity leave, supported by early medical advice of occupational physicians, may increase the chances of return-to-work after maternity leave. In addition, to understand the process of sick leave and return-to-work after childbirth it is important to gain insight into which factors hinder return-to-work after childbirth, as well, as which prognostic factors lead to the development of postpartum health complaints. In this paper, the design of the Mom@Work study is described.METHODS: The Mom@Work study is simultaneously a randomised controlled trial and a cohort study. Pregnant women working for at least 12 hours a week at one of the 15 participating companies are eligible to participate. The supervisors of these pregnant employees are randomised at 35 weeks pregnancy into the intervention group or control group. During maternity leave, supervisors in the intervention group contact their employee six weeks after delivery using a structured interview. When employees do not expect to return to their jobs at the end of their scheduled maternity leave due to health problems, the supervisor offers early support of the occupational physician. Supervisors in the control group have no structural contact with their employees during maternity leave. Measurements take place at 30 weeks pregnancy and at 6, 12, 24 and 52 weeks postpartum. In addition, cost data are collected. For the RCT, primary outcome measures are sick leave and return-to-work, and secondary outcome measures are costs, health, satisfaction with intervention and global feelings of recovery. Outcome measures for the cohort are pregnancy-related pelvic girdle pain, fatigue and depression. Finally, a number of prognostic factors for return-to-work and for the development of complaints will be measured.DISCUSSION: The Mom@Work study will provide important information about return-to-work of employees after giving birth. Results will give insight in prognosis of postpartum sick leave and complaints. Also, the role of supervisors and occupational physicians in successful return-to-work after childbirth will be clarified.

AB - BACKGROUND: Many women suffer from health problems after giving birth, which can lead to sick leave. About 30% of Dutch workers are on sick leave after maternity leave. Structural contact of supervisors with employees on maternity leave, supported by early medical advice of occupational physicians, may increase the chances of return-to-work after maternity leave. In addition, to understand the process of sick leave and return-to-work after childbirth it is important to gain insight into which factors hinder return-to-work after childbirth, as well, as which prognostic factors lead to the development of postpartum health complaints. In this paper, the design of the Mom@Work study is described.METHODS: The Mom@Work study is simultaneously a randomised controlled trial and a cohort study. Pregnant women working for at least 12 hours a week at one of the 15 participating companies are eligible to participate. The supervisors of these pregnant employees are randomised at 35 weeks pregnancy into the intervention group or control group. During maternity leave, supervisors in the intervention group contact their employee six weeks after delivery using a structured interview. When employees do not expect to return to their jobs at the end of their scheduled maternity leave due to health problems, the supervisor offers early support of the occupational physician. Supervisors in the control group have no structural contact with their employees during maternity leave. Measurements take place at 30 weeks pregnancy and at 6, 12, 24 and 52 weeks postpartum. In addition, cost data are collected. For the RCT, primary outcome measures are sick leave and return-to-work, and secondary outcome measures are costs, health, satisfaction with intervention and global feelings of recovery. Outcome measures for the cohort are pregnancy-related pelvic girdle pain, fatigue and depression. Finally, a number of prognostic factors for return-to-work and for the development of complaints will be measured.DISCUSSION: The Mom@Work study will provide important information about return-to-work of employees after giving birth. Results will give insight in prognosis of postpartum sick leave and complaints. Also, the role of supervisors and occupational physicians in successful return-to-work after childbirth will be clarified.

KW - Adult

KW - Cohort Studies

KW - Confidence Intervals

KW - Employment/statistics & numerical data

KW - Female

KW - Follow-Up Studies

KW - Health Education/methods

KW - Humans

KW - Multivariate Analysis

KW - Netherlands

KW - Parental Leave/standards

KW - Personnel Management/methods

KW - Postpartum Period

KW - Pregnancy

KW - Probability

KW - Research Design

KW - Risk Assessment

KW - Sick Leave/statistics & numerical data

KW - Time Factors

KW - Women, Working/psychology

U2 - 10.1186/1471-2458-7-43

DO - 10.1186/1471-2458-7-43

M3 - Article

VL - 7

SP - 43

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

ER -